Apollomics, Inc. (APLM) vs Celularity Inc. (CELU)
A side-by-side comparison of Apollomics, Inc. and Celularity Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$22.70HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
CELU
Celularity Inc.
$1.72HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — APLM vs CELU
growth of $100 · dividends reinvested · last 5yAPLM -97.6% (-52.8%/yr)CELU -97.4% (-51.7%/yr)CELU compounded faster over this window
APLM CELU
APLM vs CELU: by the numbers
- •CELU is the larger company ($50M vs $50M market cap).
- •Both run net losses; APLM's is the smaller (-128.69% vs -375.77% net margin).
- •APLM grew revenue faster over the past five years (35.84% vs 8.31% CAGR).
Metrics side by side
Valuation
| Metric | APLM | CELU |
|---|---|---|
| P/S ratio | N/A | 2.63 |
Profitability
| Metric | APLM | CELU |
|---|---|---|
| Gross margin | 97.00% | 79.62% |
| Operating margin | -111.45% | -230.92% |
| Net margin | -128.69% | -375.77% |
| ROIC | -2441.49% | -192.99% |
Growth (annualized)
| Metric | APLM | CELU |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | 8.31% |
| Total return CAGR (5Y) | N/A | -52.57% |
Frequently asked
- Which has grown faster, APLM or CELU?
- Over the past five years, APLM grew revenue faster — APLM at a 35.84% CAGR versus CELU at 8.31%.
Go deeper
Dig into the metrics
Apollomics ROECelularity ROEApollomics operating marginCelularity operating marginApollomics revenue growthCelularity revenue growthApollomics free cash flowCelularity free cash flow
Apollomics & Celularity appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.